A Russian State Duma deputy, Leonid Ivlev, claimed Ukraine's biological laboratories, funded by the US, align with Kiev's "militaristic policy." He cited research on dangerous pathogens and alleged prior preparations for conflict with Moscow.
Russia's Foreign Ministry claims the US studied diseases not typical for the region in its biolabs in Ukraine. Moscow also warned of a "devastating" response to any NATO attack on Russian regions and criticized Western policies.
A new non-invasive prenatal test (NIPT) called NIFS can screen for thousands of severe genetic diseases by analyzing fetal DNA from maternal blood, with over 97% accuracy. Developed by researchers from the Broad Institute, this technology promises to reduce reliance on invasive procedures like amniocentesis, though concerns about over-screening and parental anxiety have been raised.
South Korea and Italy held their 13th Joint Science and Technology Committee meeting in Rome, agreeing to enhance cooperation in AI, climate change, and brain disease research. This marks the first meeting in five years, following South Korea's accession to Horizon Europe as an associate member.
DSÖ Baş bilim insanı Dr. Sylvie Briand, zoonotik hastalıkların insan hareketliliği, arazi kullanımı ve iklim değişikliği gibi faktörlerle arttığını belirtti. Kovid-19'un zamanla daha az ölümcül hale geldiğini ekledi.
France's 2026 social security budget may restrict reimbursement for certain chronic illnesses, potentially impacting patients with long-term conditions not currently considered "non-exempt".
Zoonotic diseases, originating from animals like rodents and bats, pose significant global health, economic, and social risks. WHO expert Dr. Sylvie Briand highlights changing human-animal interactions, increased mobility, and climate change as key drivers, noting that while some diseases are preventable, others like COVID-19 and Ebola have had profound impacts.
A measles outbreak in southern Utah, fueled by low vaccination rates, has overwhelmed public health departments, highlighting a broader decline in vaccine confidence and public health infrastructure across the US.
Oxford University begins human trials for the world's first AI-designed vaccine, targeting Crimean-Congo haemorrhagic fever (CCHF), a deadly virus with 40% mortality rates and no widely approved vaccine, using AI to accelerate development by analyzing genetic data to identify immune response triggers.
Google's "Debug" project plans to release 64 million male mosquitoes carrying the Wolbachia bacteria in California and Florida over two years to reduce disease-carrying mosquito populations. The EPA is seeking public comment on the experimental use permit.
As the 2026 FIFA World Cup expands across the US, Canada, and Mexico, health officials are preparing for infectious disease threats, prioritizing measles and respiratory viruses over Ebola due to lower transmission risk. Enhanced surveillance and screening measures are in place.
Chikungunya virus, spread by Aedes mosquitoes, is expanding its reach due to climate change, posing a threat to Turkey. Experts emphasize personal protection and early diagnosis as there's no specific antiviral treatment, though two vaccines are available abroad.
A new issue of the American Journal of Public Health reveals how tobacco companies like Philip Morris and RJ Reynolds used strategies developed for selling cigarettes to market ultra-processed foods (UPFs), including Lunchables, to children. These strategies focused on optimizing formulations for rapid reward and creating addictive products. UPFs are linked to increased risks of dementia, cognitive decline, cardiovascular diseases, and certain cancers.
A study by the Italian Institute for Planetary Health (Iiph) confirms that global warming significantly impacts human health, increasing diseases, especially infectious ones, and mental health issues. Extreme weather events and economic damage further exacerbate the problem.
India's NFHS-6 survey shows a significant rise in obesity and high blood sugar levels among adults. Nearly 1 in 3 women and over 1 in 4 men are overweight or obese, with southern and coastal regions emerging as hotspots for these lifestyle diseases.
A new analysis shows semaglutide (Ozempic/Wegovy) slows kidney disease progression in type 2 diabetes patients, improving kidney function and survival rates, even with a history of cardiovascular events. The drug mimics GLP-1 hormones and is also popular for weight loss.
Russia has completed development of three domestic drugs for Duchenne muscular dystrophy, short bowel syndrome, and cystic fibrosis. The medications were created by scientists at the Research Institute of Hygiene, Occupational Pathology, and Human Ecology of the FMBA.
Kenyans are protesting a US plan to establish an Ebola quarantine facility for its citizens in Nanyuki, fearing it will expose them to the virus and highlight double standards. The proposal has led to protests, court challenges, and debate, with some officials defending it as a health preparedness measure.
Google's Debug program plans to release 16 million sterile male Aedes aegypti mosquitoes in Florida and California to combat disease spread. These sterile males, infected with Wolbachia bacteria, will prevent wild females from producing viable offspring, aiming to reduce the invasive mosquito population.
Google's 'Debug' program is seeking EPA permission to release up to 32 million sterile male mosquitoes in California and Florida over two years. The method uses the wolbachia bacteria to prevent offspring, aiming to reduce disease-spreading insects.
Alphabet's Verily is seeking EPA approval to release 32 million Wolbachia-infected male mosquitoes in California and Florida to combat diseases like West Nile virus. The project aims to shrink local mosquito populations by preventing viable egg hatching.
Alphabet's Verily is seeking EPA approval to release 32 million male mosquitoes in California and Florida to combat diseases like West Nile virus. The plan uses Wolbachia bacteria to reduce mosquito populations.
Alphabet's Verily seeks EPA approval to release 32 million Wolbachia-infected male mosquitoes in CA and FL over two years to combat mosquito-borne diseases like West Nile virus.
Alphabet's Verily is seeking EPA approval to release 32 million male mosquitoes in California and Florida to combat diseases like West Nile virus. The plan uses AI and robotics to breed and release mosquitoes infected with Wolbachia bacteria, which prevents eggs from hatching.
